# Nrf2 inhibition overcomes regorafenib resistance in well-differentiated sorafenib-resistant hepatocellular carcinoma cells

Source: [Biological sciences : nature.com subject feeds](https://www.nature.com/articles/s41598-026-79897-x) · 2026-11-13 · Life
Page: https://themorning.science/story/nrf2-inhibition-overcomes-regorafenib-resistance-in-well-differentiated-sorafeni-6e51219727f3ae3d
Kind: research · Impact: low

## In brief

- The study reports that Nrf2 inhibition overcame regorafenib resistance in well-differentiated sorafenib-resistant hepatocellular carcinoma cells.
- No summary was provided, so these points rest on the article title alone.

## Why it matters

Drug resistance is a central obstacle in cancer treatment research, so a way to overcome resistance in liver cancer cells is relevant to researchers in this field.

## Timeline

- 2026-11-13: Study listed in nature.com subject feed

## Coverage

- [Nrf2 inhibition overcomes regorafenib resistance in well-differentiated sorafenib-resistant hepatocellular carcinoma cells](https://www.nature.com/articles/s41598-026-79897-x) — Biological sciences : nature.com subject feeds, 2026-11-13

Tags: liver cancer, drug resistance, nrf2, regorafenib, hepatocellular carcinoma

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science